Vitae Pharmaceuticals, Inc.
Vitae Initiates Phase 1 Trial of Novel Renin Inhibitor
Published in Biotech Business Week, October 5th, 2009
VTP-27999 is a novel, proprietary renin inhibitor discovered and advanced by Vitae. "Renin inhibition offers a powerful approach to blood pressure control because renin is the first and rate limiting enzyme in the primary biochemical pathway for regulating the body's blood pressure", said Richard Gregg, MD, chief scientific officer at Vitae. "Also, renin is found in critical organs throughout the body such as the heart, brain and kidney. By inhibiting renin directly, VTP-27999 should provide...
This article not available for purchase.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- American Associates, Ben-Gurion University of the Negev
Ben-Gurion University Alzheimer's researcher demonstrates specific immune response to vaccine - American Roentgen Ray Society
Despite ongoing safety concerns, study finds adverse reactions from contrast agents rarely occur - BioMed Central
'Back-breaking' work beliefs contribute to health workers' pain - BioMed Central
Binge drinkers let down guard against infection - BioMed Central
Echoes of phlogiston in stem cell biology - BioMed Central
Increased risk of birth defects after PCE exposure - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
